India, June 10 -- SOUTH CENTRAL RAILWAY has issued a tender notice titled "(Ph No.:49192) Itolizumab Inj. (Dna Origin) 25 Mg/5 Ml (Alzumab) Inj 5 Ml" with the tender reference no.: LX255349.

The tender details are as follows: (PH NO.:49192) ITOLIZUMAB INJ. (DNA ORIGIN) 25 MG/5 ML (ALZUMAB) INJ 5 ML [ Warr anty Period: 30 Months after the date of delivery ] ]

Contract Category: Expenditure

The expression of interest should be received by June 16.

For more information, contact SOUTH CENTRAL RAILWAY, Address: NED/DIV/SOUTH CENTRAL RLY Maharashtra, Nanded - 431601.

City: Nanded

District: Nanded

State: Maharashtra

Pin: 431601

Tel/Fax: +91-2462-260694, cos@scr.railnet.gov.in.

Disclaimer: Curated by HT Syndication....